Related Experiment Video
Updated: Jun 24, 2026

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Some cardiomyopathy-causing troponin I mutations stabilize a functional intermediate actin state
Mohit C Mathur1, Tomoyoshi Kobayashi, Joseph M Chalovich
1Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Abstract:
We examined four cardiomyopathy-causing mutations of troponin I that appear to disturb function by altering the distribution of thin filament states. The R193H (mouse) troponin I mutant had greater than normal actin-activated myosin-S1 ATPase activity in both the presence and absence of calcium. The rate of ATPase activity was the same as that of the wild-type at near-saturating concentrations of the activator, N-ethylmaleimide-S1. This mutant appeared to function by stabilizing the active state of thin filaments. Mutations D191H, R146G, and R146W had lower ATPase activities in the presence of calcium, but higher activities in the absence of calcium. These effects were most pronounced with mutations at position 146. For all three mutants the rates were similar to those of the wild-type at near-saturating concentrations of N-ethylmaleimide-S1. These results, combined with previous results, show that any alteration in the normal distribution of actomyosin states is capable of producing cardiomyopathy. The results of the D191H, R146G, and R146W mutations are most readily explained if the intermediate state of regulated actin has a unique function. The intermediate state appears to have an ability to accelerate the rate of ATP hydrolysis by myosin that exceeds that of the inactive state.
Insights
Cardiomyopathy can result from disruptions in troponin I function, affecting thin filament states. Mutations alter actin-myosin interactions, highlighting the importance of normal actomyosin state distribution for cardiac health.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Cardiomyopathy is often linked to genetic mutations affecting cardiac muscle function.
- Troponin I plays a critical role in regulating the interaction between actin and myosin in muscle contraction.
- Understanding how troponin I mutations alter thin filament states is crucial for deciphering disease mechanisms.
Purpose of the Study:
- To investigate the functional consequences of four specific cardiomyopathy-causing mutations in troponin I.
- To determine how these mutations affect the distribution of thin filament states and actomyosin interactions.
- To elucidate the role of intermediate actin states in muscle regulation and disease.
Main Methods:
- Biochemical assays measuring actin-activated myosin-S1 ATPase activity.
- Analysis of mutant troponin I proteins (R193H, D191H, R146G, R146W) in the presence and absence of calcium.
- Comparison of ATPase rates with wild-type troponin I and at near-saturating activator concentrations.
Main Results:
- The R193H mutant showed increased ATPase activity, suggesting stabilization of the active thin filament state.
- Mutants D191H, R146G, and R146W exhibited altered ATPase activity dependent on calcium levels, with pronounced effects at position 146.
- All mutants showed wild-type rates at saturating activator concentrations, indicating specific alterations in calcium-dependent regulation.
Conclusions:
- Any disruption in the normal distribution of actomyosin states can lead to cardiomyopathy.
- The intermediate state of regulated actin appears to possess a unique function in accelerating ATP hydrolysis.
- These findings underscore the critical role of precise regulation of actin-myosin dynamics in preventing cardiac disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Sarcomere
Each myosin...
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Actin and Myosin in Muscle Contraction
Cross-bridge Cycle
Cardiomyopathy I: Introduction and Classification

